Related Experiment Video
Updated: Aug 6, 2026

Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis
Published on: December 21, 2014
Fibrin D-dimer and cardiovascular risk
1Division of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.
Insights
Fibrin D-dimer assays, used to detect blood clot formation and breakdown, are linked to cardiovascular disease risks. Further research is needed to confirm D-dimer
Area of Science:
- Cardiovascular Medicine
- Hematology
- Clinical Chemistry
Background:
- Fibrin D-dimer is a key biomarker for detecting coagulation activation and fibrinolysis in blood.
- Previous studies over 15 years have associated D-dimer levels with increased cardiovascular disease (CVD) risks.
Purpose of the Study:
- To review the analytic, preanalytic, and clinical associations of Fibrin D-dimer.
- To explore the role of D-dimer in various thromboembolic conditions and cardiovascular risk prediction.
Main Methods:
- Comprehensive literature review of studies on Fibrin D-dimer and cardiovascular diseases.
- Analysis of associations between D-dimer and risk factors, coronary heart disease, atrial fibrillation, stroke, peripheral arterial disease, and venous thromboembolism.
Main Results:
- D-dimer is associated with risks of coronary heart disease, atrial fibrillation, stroke, peripheral arterial disease, and venous thromboembolism.
- These findings suggest that activated coagulation and fibrinolysis may contribute to arterial, intracardiac, and venous thromboembolism.
Conclusions:
- Fibrin D-dimer shows potential utility in predicting cardiovascular risk and identifying patients for anticoagulation therapy.
- Further studies are required to validate D-dimer's clinical utility, and assay harmonization is crucial for improved clinical application.
Abstract:
Fibrin D-dimer, the most commonly used clinical assay for detection of coagulation activation and in vivo fibrin formation and lysis in circulating blood, has been associated with risks of cardiovascular diseases in studies published over the past 15 years. This review discusses, in turn, analytic and preanalytic considerations; associations with risk factors; and associations with coronary heart disease, atrial fibrillation, stroke and cerebrovascular disease, peripheral arterial disease, and venous thromboembolism. These associations suggest that activated coagulation and in vivo fibrin formation and lysis may play a role in arterial, intracardiac, and venous thromboembolism. The potential clinical utility of D-dimer in prediction of cardiovascular risk, in indicating patient groups for prophylactic anticoagulation and in monitoring of anticoagulation, requires further study. Harmonization of results from different assays would increase clinical utility.
Related Concept Videos
Fibronectins Connect Cells with ECM
Both proteoglycans and collagen are attached to fibronectin proteins, which, in turn, are attached to integrin proteins. These integrin proteins interact with transmembrane...
Intracellular Signaling Affects Focal Adhesions
Some...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Clot Retraction and Fibrinolysis
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease II: Pathophysiology

